Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Greenwich LifeSciences (GLSI) Invested Capital (2019 - 2025)

Greenwich LifeSciences filings provide 7 years of Invested Capital readings, the most recent being $2.2 million for Q3 2025.

  • Quarterly Invested Capital fell 56.15% to $2.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Sep 2025, down 56.15% year-over-year, with the annual reading at $2.5 million for FY2024, 62.18% down from the prior year.
  • Invested Capital hit $2.2 million in Q3 2025 for Greenwich LifeSciences, up from $1.4 million in the prior quarter.
  • Across five years, Invested Capital topped out at $29.7 million in Q1 2021 and bottomed at $1.3 million in Q1 2025.
  • Average Invested Capital over 5 years is $12.7 million, with a median of $10.6 million recorded in 2023.
  • The largest annual shift saw Invested Capital skyrocketed 2193.22% in 2021 before it crashed 75.5% in 2025.
  • Greenwich LifeSciences' Invested Capital stood at $26.8 million in 2021, then plummeted by 50.75% to $13.2 million in 2022, then tumbled by 49.29% to $6.7 million in 2023, then plummeted by 62.18% to $2.5 million in 2024, then decreased by 13.77% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for GLSI's Invested Capital are $2.2 million (Q3 2025), $1.4 million (Q2 2025), and $1.3 million (Q1 2025).